STAT Madness is on
March 2, 2022 Two discoveries from Carolina are competing in this bracket-style national tournament to find the best innovations in science and medicine. Start voting!
Ralph Baric
Category
Ralph Baric
The pills to fight COVID-19
January 12, 2022 There are new weapons in the war against COVID-19: antiviral pills that fight the virus before it multiplies and causes major damage.
Baric among 9 to receive 2020-21 North Carolina Awards, state’s highest honor
November 18, 2021 Dr. Ralph Baric has been selected as a recipient of the state’s highest civilian honor, the North Carolina Award. He will receive the 2020 North Carolina Award for Science to recognize his work in response to the COVID-19 pandemic.
9 Gillings School faculty members named to Clarivate's annual Highly Cited Researchers list
November 16, 2021 Nine academics from the Gillings School were recently named to the 2021 Highly Cited Researchers list from Clarivate. The highly anticipated annual list identifies researchers who demonstrated significant influence in their chosen field or fields through the publication of multiple highly cited papers during the last decade.
Duke, UNC-Chapel Hill scientists identify new antibody for COVID-19 and variants
November 2, 2021 A research collaboration between scientists at Duke University and the University of North Carolina at Chapel Hill has identified and tested an antibody that limits the severity of infections from a variety of coronaviruses, including those that cause COVID-19 as well as the original SARS illness.
Cellular quality-control system identified as a culprit in coronavirus infection
November 1, 2021 MERS, caused by a coronavirus strain of the same name, holds clues for respiratory diseases like COVID-19.
Dr. Ralph Baric receives O. Max Gardner Award for coronavirus research
October 12, 2021 UNC-Chapel Hill professor Dr. Ralph Baric — a world renowned coronavirus expert — has contributed to the development of life-saving vaccines and pharmaceutical treatments during the COVID-19 pandemic.
Carolina research produces effective experimental pill to treat COVID-19
October 1, 2021 University of North Carolina at Chapel Hill research set the stage to seek emergency authorization of the first oral antiviral drug to treat COVID-19.
New universal vaccine effectively targets coronaviruses
June 22, 2021 Scientists at the UNC Gillings School have developed a universal vaccine that could protect against COVID-19, its variants — and the next coronavirus pandemic.
Expertscape recognizes several Gillings faculty as top-rated in their fields
May 27, 2021 Expertscape, an online database that assesses and ranks the expertise and contributions of physicians and medical institutions worldwide, rated multiple UNC biomedical researchers as top-rated experts in their fields for its 2021 rankings.